Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Medical Genetics and Orphan Drugs Csaba Mera, MD Medical Director, ODS Portland Actuarial Club November 17, 2009 Broadway Room, Heathman Hotel EXPERIMENTS IN PLANT HYBRIDIZATION (1865) 1822-1884 Mendel, Gregor. Versuche über Plflanzenhybriden. Verhandlungen des naturforschenden Vereines in Brünn, Bd. IV für das Jahr 1865, Abhandlungen, 3–47. "We have found the secret of Life." James D. Watson and Francis Crick propose the double helix structure of DNA – 1953 Victor McKusick Founding father of medical genetics First medical genetics program Johns Hopkins 1957 Early advocate of mapping the human genome Lasker Award for Special Achievement in Medical Science 1997 February 2001 - joint publications Improved drafts in 2003 and 2005 Human genome ~ 24,000 genes All human races are 99.99 % alike, Genetic archaeology – new understanding Changes in the Foxp2 gene during the course of evolution resulted in the development of language in humans It took 6 million years but now I can really SPEAK!! 6 M yrs – Two fixed amino acid changes 130 M yrs One amino acid change The Journey of Man Dr. Spencer Wells – National Geographic Explorer-in-Residence Compendium of human genes and genetic phenotypes Comprehensive, authoritative, timely (updated daily) Links to other genetics resources The full-text, referenced overviews on all known mendelian disorders and over 12,000 genes http://www.ncbi.nlm.nih.gov/omim/ BRCA1 and BRCA2 ◦ ◦ ◦ ◦ About 10% of breast cancer patients ~ 20,000 cases $2,000 per test $40, 000,000 annually HNPCC ◦ ◦ ◦ ◦ About 5% of colon cancer patients ~7,000 cases $2,000 per test $14,000,000 annually Lawrence WF, et al. Cost of Genetic Counseling and Testing for BRCA1 and BRCA2 Breast Cancer Susceptibility Mutations1Vol. 10, 475–481, May 2001 Cancer Epidemiology, Biomarkers & Prevention Relationship testing • Chain of custody • In home • $200 - $500 Disease prediction • Genomewide association study • Not ready for prime time Genentech 1978 recombinant DNA to induce E. coli to produce human insulin 1978 Growth hormone Blood clotting factors for hemophilia Gonadotropins Hepatitis B vaccine >350 drugs being tested Characteristics that differentiate specialty drugs from traditional drugs include ◦ ◦ ◦ ◦ ◦ ◦ ◦ ◦ Recombinant DNA technology or other biological process Target diseases with no currently available treatments Injection or infusion* Complex handling requirements Requires close monitoring and support Patient education and coordination of care needed Higher risk of severe side effects High cost (CMS = $600 or more per patient per month) *Although, fastest growing route of administration is oral Adapted from EMD Serono Injectables Digest 5thEdition The Orphan Drug Act (ODA) of January 1983 Lobbying from the National Organization for Rare Disorders Encourages pharmaceutical companies to develop drugs for diseases that have a small market through: ◦ ◦ ◦ ◦ ◦ Tax incentives Enhanced patent protection and marketing rights Modified clinical testing requirement Clinical research financial subsidization Creating a government-run enterprise to engage in research and development Drug Disease Disease Prevalence Cost/30 days Cinryze C1 inhibitor 20,000 $45,000 Fabrazyme Fabry disease 2,600 $11,250 Stelara Psoriasis 500,000 $11,200 Nplate Chronic ITP 3,000 $9,000 Avastin Advanced breast cancer 40,000 $8,000 Afinitor Advanced renal cancer 13,000 $6,000 Temodar Advanced brain 10,000 $3,200 Cinryze (C1 INHIBITOR, HUMAN) $45,000 / 30 day supply cancer Nplate (ROMIPLOSTIM) $9,000 / 30 day supply Annual Promacta (ELTROMBOPAG) 588,600 $6,986,250,000 $3,300 / 30 day supply A leading cause of blindness Prevalence of AMD 1.75 million in 2009 (3 million by 2020) Ranibizumab o Recombinant monoclonal antibody Binds to and inhibits all the biologically active forms of vascular endothelial growth factor A Monthly vitreous injection monthly Duration of treatment - indefinitely Prevents vision loss, improves visual acuity Cost - $1,950 per dose o 1.75M x $1,950 = $41 Billion annually o o o o o Steinbrook R. The Price of Sight — Ranibizumab, Bevacizumab, and the Treatment of Macular Degeneration. NEJM 2006; 355:1409-1412 Epidermal growth factor receptor (EGFR) transmits signals through a set of intracellular proteins, which instruct cancer cells to reproduce and metastasize. Blocking EGFR stops this malignant signaling. Two chemotherapy drugs: Erbitux and Vectibix However, in patients with mutant V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), the signaling continues despite EGFR therapy. Mutated KRAS genes have been detected in about 40% of metastatic colorectal cancer patients, depending on the testing used. 28,274 patients annually Van Cutsem et al J Clin Oncol 2007; 25[18S]:4000) Cost of KRAS testing at a commercial laboratory: $452/test Average wholesale price of Erbitux loading dose of 400 mg/m2 = $3,986/dose weekly dose of 250 mg/m2 = $2491/dose Mean number of Erbitux infusions: 24 Drug cost per patient = $61,279 Median survival BSC 4.6 months BSC+Erbitux 6.1 months Testing and treatment cost for all patients $630 Million Van Cutsem et al J Clin Oncol 2007; 25[18S]:4000) BSC + Vectibix vs. BSC alone Jonker DJ, et al. New England Journal of Medicine, November 15, 2007. Is it worth it? NAME Jason Alexander Woody Allen Mario Andretti Sean Astin Ludwig Van Beethoven David Ben-Gurion Robert Blake Humphrey Bogart Napoleon Bonaparte Bono Matthew Broderick Mel Brooks Gary Burghoff Richard Burton James Cagney Truman Capote Andrew Carnegie Gary Coleman Phil Collins Lou Costello Tom Cruise Billy Crystal Salvador Dali Sammy Davis Jr. Danny DeVito Robert Downey Jr. HEIGHT 5'5" 5'6" 5' 7½" 5'6" 5' 3¾" 5'0" 5'4" 5'8" 5'6" 5'7" 5'8" 5'4" 5' 5" 5'8" 5'7" 5'4" 5'0" 4'8" 5' 6" 5' 5" 5'8" 5'8" 5'7" 5'3" 5'0" 5'7" NAME AREA Entertainment Entertainment Sports Entertainment Music Politics Entertainment Entertainment Politics Entertainment Entertainment Entertainment Entertainment Entertainment Entertainment Literature Entrepreneur Entertainment Entertainment Entertainment Entertainment Entertainment Art Entertainment Entertainment Entertainment 5'6" Entertainment Emilio Estevez 5'7" Entertainment Peter Falk 5'6" Entertainment William Faulkner 5'6" Literature F. Scott Fitzgerald 5'7" Literature Michael J. Fox 5'4" Entertainment Buckminster Fuller 5'2" Scientist Ghandi 5'3" Politics Paul Giamatti 5'7" Entertainment Maurice & Robin Gibb (Bee Gees) 5'8" Entertainment Joel Grey 5'5" Entertainment Gus Grissom 5' 5" Astronaut Scott Hamilton 5'4" Sports Armand Hammer 5'5" Entrepreneur Alfred Hitchcock 5'6" Entertainment Dustin Hoffman 5'6" Entertainment Anthony Hopkins 5'8" Entertainment Bob Hoskins Andrew Carnegie 5’ 0” HEIGHT AREA Bob Dylan 5' 5½" Entertainment Harry Houdini 5'5" Curly Howard 5' 5" Entertainment Entertainment Moe Howard 5'4" Entertainment Elton John 5'4" Entertainment Davy Jones 5'3" Entertainment John Keats 5'1" Literature Ben Kingsley 5'8" Entertainment Nikita Khrushchev 5'3" Politics Targeted drug therapy Genetic profiling Gene therapy Genetic manipulation Expenditures will grow >15% compared to <5% for conventional drugs Specialty drugs are >50% of those in Phase III development Oral therapies may augment or replace existing injected or infused agents. Atheer Kaddis, PharmD and Debbie Stern, RPh Academy of Managed Care Pharmacy - Fall Educational Conference - October 9, 2009